drugset / Trial / NCT06246071
A Study of TYK-00540 in Adult Patients With Solid Tumors
NaSequentialOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the safety and tolerability of TYK-00540, with dose-escalation stage and dose-expansion stage.
Timeline
- Start
- 2024-01-02
- Primary completion
- 2026-12-05
- Completion
- 2026-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TYK-00540 | Unknown | — | Oral |
Indications
No indication recorded.